Cheung Kong trials CK Life

Investor presentations begin in Singapore next Tuesday for Li Ka-shing''s latest investment vehicle, Cheung Kong Life Sciences.
June 25, 2002

A roughly $300 million GEM listing for the biotech arm of the Cheung Kong empire is already starting to whip up a media frenzy and lead manager Salomon Smith Barney is undoubtedly hoping that retail investors are about to shortly follow suit.

Sign In to Your Account To Access Exclusive FinanceAsia Content!

Please sign in to your subscription to unlock full access to our premium FA resources.

Free Registration & 7-Day Trial
Register now to enjoy a 7-day free trial - no registration fees required. Click the link to get started.

Note: This free trial is a one-time offer.

Questions?
If you have any enquiries or would like a quote for a team or company licence, please contact us at [email protected]. Our subscription team will be happy to assist you.

Share our publication on social media
Share our publication on social media